Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Intimeo
- Development stage
- Unknown
- Lead developer
- Novonesis
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Intimeo is an oral probiotic dietary supplement designed to support and maintain the balance of the vaginal and urogenital microbiota. It contains a patented blend of four live Lactobacillus strains: Lactobacillus crispatus LBV88 (DSM 22566), Lactobacillus rhamnosus LBV96 (DSM 22560), Lactobacillus gasseri LBV150 (DSM 22583), and Lactobacillus jensenii LBV116 (DSM 22567), collectively known as the Astarte probiotic blend. Originally developed by HSO Health Care GmbH (later acquired by Chr. Hansen, which subsequently merged into Novonesis), the formulation is clinically documented to colonize the vaginal tract, lower vaginal pH, and inhibit the growth of pathogens such as Escherichia coli and Gardnerella vaginalis. It is marketed by Lagap in Switzerland and Frezyderm in Greece for the prevention and treatment of vaginal dysbiosis, bacterial vaginosis, and recurrent urinary tract infections.
- Brand names
- Intimeo
- Other names
- Astarte probiotic blendLactobacillus crispatus + Lactobacillus rhamnosus + Lactobacillus gasseri + Lactobacillus jenseniiLactobacillus crispatus LBV88 + Lactobacillus rhamnosus LBV96 + Lactobacillus gasseri LBV150 + Lactobacillus jensenii LBV116
Beyond the preview
Go deeper on Intimeo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Intimeo.